Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07865442
PHASE1

First in Human Study of ALT-01 in Healthy Participants

Sponsor: Altis Medicines, Inc

View on ClinicalTrials.gov

Summary

The primary objective of the study is to evaluate the safety and tolerability of ALT-01 in healthy participants

Official title: First in Human, Randomized, Blinded, Placebo-Controlled Single Ascending Dose Study of ALT-01 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-10-26

Completion Date

2027-09-30

Last Updated

2026-10-13

Healthy Volunteers

Yes

Interventions

DRUG

ALT-01

Subcutaneous injection

DRUG

Placebo

Subcutaneous injection

Locations (1)

Altis Site

Adelaide, South Australia, Australia